My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Ess Dee Aluminium to hold board meeting
Sep 09,2016

Ess Dee Aluminium will hold a meeting of the Board of Directors of the Company on 14 September 2016.

Powered by Capital Market - Live News

Welspun Enterprises to hold board meeting
Sep 09,2016

Welspun Enterprises will hold a meeting of the Board of Directors of the Company on 14 September 2016.

Powered by Capital Market - Live News

Adhunik Metaliks to hold board meeting
Sep 09,2016

Adhunik Metaliks will hold a meeting of the Board of Directors of the Company on 14 September 2016.

Powered by Capital Market - Live News

Panther Industrial Products to hold board meeting
Sep 09,2016

Panther Industrial Products will hold a meeting of the Board of Directors of the Company on 14 September 2016.

Powered by Capital Market - Live News

Advance Lifestyles to hold board meeting
Sep 09,2016

Advance Lifestyles will hold a meeting of the Board of Directors of the Company on 13 September 2016.

Powered by Capital Market - Live News

Secure Earth Technologies to hold board meeting
Sep 09,2016

Secure Earth Technologies will hold a meeting of the Board of Directors of the Company on 9 September 2016, to Approve the sale of shares of wholly owned subsidiaries namely Synergy Log-in Systems Sdn Bhd, Malaysia, Sigma Soft Pte Ltd., Singapore Globsyn Technologies Inc., USA and Synergy Information Technology Inc., USA.

Powered by Capital Market - Live News

Saurashtra Cement to hold board meeting
Sep 09,2016

Saurashtra Cement will hold a meeting of the Board of Directors of the Company on 14 September 2016, to consider a proposal to make final call for Rs. 5.00 per share on 1,80,00,000 equity shares to make the shares fully paid-up.

Powered by Capital Market - Live News

C Mahendra Exports to hold board meeting
Sep 09,2016

C Mahendra Exports will hold a meeting of the Board of Directors of the Company on 8 September 2016, to consider and approve Notice of Postal Ballot for approval of Members, for Appointment of Statutory Auditors of the Company.

Powered by Capital Market - Live News

P C Products India to hold AGM
Sep 09,2016

P C Products India announced that the 20th Annual General Meeting (AGM) of the company will be held on 30 September 2016.

Powered by Capital Market - Live News

RattanIndia Power to hold AGM
Sep 09,2016

RattanIndia Power announced that the 9th Annual General Meeting (AGM) of the company will be held on 30 September 2016.

Powered by Capital Market - Live News

SVP Global Ventures to hold AGM
Sep 09,2016

SVP Global Ventures announced that the 34th Annual General Meeting (AGM) of the company will be held on 30 September 2016.

Powered by Capital Market - Live News

TPL Plastech to hold AGM
Sep 09,2016

TPL Plastech announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2016.

Powered by Capital Market - Live News

Olympic Oil Industries to hold AGM
Sep 09,2016

Olympic Oil Industries announced that the 36th Annual General Meeting (AGM) of the company will be held on 28 September 2016.

Powered by Capital Market - Live News

Sree Rayalaseema Alkalies&Allied Chem to hold AGM
Sep 09,2016

Sree Rayalaseema Alkalies&Allied Chem announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2016.

Powered by Capital Market - Live News

Suven Life Sciences gains after securing three product patents
Sep 09,2016

The announcement was made during market hours today, 9 September 2016.

Meanwhile, the BSE Sensex was down 215.31 points, or 0.74%, to 28,829.97.

Higher than normal volumes were witnessed on the counter. On BSE, so far 99,636 shares were traded in the counter, compared with average daily volume of 61,833 shares in the past one quarter. The stock hit a high of Rs 205.10 and a low of Rs 196.20 so far during the day. The stock hit a 52-week high of Rs 308.70 on 5 October 2015. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past one month till 8 September 2016, falling 2.07% compared with Sensexs 3.06% gains. The scrip had also underperformed the market in past one quarter, dropping 6.7% as against Sensexs 7.49% gains.

The mid-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced that it was granted one product patent from Canada, one product patent from Europe and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases. These patents are valid through 2030, 2032 and 2032 respectively.

The granted claims of the patents are from the mechanism of action include the class of selective 5-HT4 compounds and H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, major depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of twenty four granted patents from Canada, twenty two granted patents from Europe and twenty one granted patents from Hong Kong. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be outlicensed at various phases of clinical development like at Phase-I or Phase-II, Suven Life said.

Suven Life Sciences consolidated net profit rose 58.2% to Rs 32.58 crore on 31.7% rise in net sales to Rs 133.23 crore in Q1 June 2016 over Q1 June 2015.

Suven Life Sciences is a biopharmaceutical company specializing in drug discovery and developmental activities in central nervous system disorders and contract research and manufacturing services (CRAMS).

Powered by Capital Market - Live News